Last Updated on October 9, 2024 by The Health Master
Download DCGI Notice dt 11-07-2022 Regarding Licensing of Class A and Class B Medical Devices: The drug regulator has said that the quality certificates issued by other entities shall not be a replacement for licenses to be granted by the competent licensing authority.
The Central Drugs Standard Control Organisation’s (CDSCO) clarification comes after the regulator noticed that some other entities are issuing quality certificates to the manufacturers at their own level, which is becoming a source of confusion for manufacturers as against the prescribed regulatory pathway for obtaining the licensure for such medical devices under the Medical Devices Rules (MDR), 2017.
“In this regard, it is hereby clarified that such quality certificates issued by other entities shall not be a replacement for licensure to be granted under MDR, 2017 by the competent licensing authority.
All manufacturers shall have to comply with the licensing requirement and obtain the license as per MDR, 2017, as the said rules do not recognize any such certificates which are not mentioned in it or part of it,” said Dr. V G Somani, Drugs Controller General (India).
The manufacturers shall apply for obtaining a manufacturing license for Class A and Class B medical devices through CDSCO’s online portal so that the manufacturing license can be granted by the respective State Licensing Authorities after review of the applications and audit as per the stipulated time specified in MDR, 2017 in order to avoid further delay.
The CDSCO has already taken up the issue of the timely licensing process through a notice on April 25, 2022, requesting all State Licensing Authorities to dispose of the applications received by them as per MDR, 2017 in time to avoid the disruption of the supply of such devices to patients.
A notification on April 1, 2020, directed the manufacturers and importers to upload a certificate of compliance with respect to the ISO 13485 standard accredited by the National Accreditation Board for Certification Bodies or International Accreditation Forum in respect of the medical devices as part of the registration process.
CDSCO has earlier clarified that the existence of a manufacturing license under Medical Device Rules 2017 indicates conformance to the fifth schedule (Quality Management System) of MDR-2017 and separate GMP/QMS are not prescribed for issuance by CLA/SLA under Medical Device Rules-2017.
With respect to the quality of components and raw materials to be used for further manufacturing of finished medical devices under a valid license for manufacturing, it is required that these components meet qualifying quality standards and quality management system (ISO 13485), and, if imported, need to have a free sale certificate of their finished product in the GHTF countries.
The documentary evidence of the same shall be submitted to the licensing authority (who is issuing the manufacturing license) at the time of grant of license & subsequently, as & when required. Further, it shall also be available for audit/inspection, whenever required, says the CDSCO.
The regulator has been providing a transition period of 30 months for Class A and B medical devices, which are for low risk and low-moderate risk, respectively, from the date of implementation of the notification on April 1, 2020, for the transition to the licensing regime.
During the period, the manufacturers were required to register their products on the CDSCO portal established for the purpose of the regulator and to affix the registration number on the label of such registered medical devices.
The medical devices that are of moderate-high risk (Class C) and high risk (Class D) are scheduled to complete the transition to the licensing regime in 42 months from the date of notification on April 1, 2020.
Procedure to obtain license for manufacturing of Medical Devices
Latest Notifications: Medical Devices
Classifications of Medical Devices under the provisions of MDR 2017
FAQs on Medical Devices Rules, 2017
FAQs – on Blood Pressure Monitoring Devices
FAQs – on Blood Bags and its Testing
Drug alert: 26 out of 1096 samples declared as NSQ in June 2022
DCGI grants marketing authorisation for vaccine against Cervical Cancer
Cipla Vs Sun Pharmaceuticals: “Respules” issue in court – Lets know the matte
USFDA considers to okay Over-The-Counter Birth Control Pill
Drug recall: Insulin Glargine Injection Pens recalled due to this reason
USFDA gives final nod for Type 2 Diabetes drug
USFDA issues Form 483 to Pharma Companies: Let’s know all about it
Medical Education Policy is required in India for students returning from abroad
Latest Notifications regarding Pharmaceuticals
For informative videos on Medical Devices, click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
